Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection.
预测卵巢癌对贝伐单抗的反应：一组潜在的生物标志物可用于指导治疗选择
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-13-0489
Collinson Fiona, Hutchinson Michelle, Craven Rachel A, Cairns David A, Zougman Alexandre, Wind Tobias C, Gahir Narinder, Messenger Michael P, Jackson Sharon, Thompson Douglas, Adusei Cybil, Ledermann Jonathan A, Hall Geoffrey, Jayson Gordon C, Selby Peter J, Banks Rosamonde E
